Advertisement
Singapore markets closed
  • Straits Times Index

    3,300.04
    -3.15 (-0.10%)
     
  • S&P 500

    5,195.93
    +15.19 (+0.29%)
     
  • Dow

    38,929.86
    +77.59 (+0.20%)
     
  • Nasdaq

    16,389.41
    +40.16 (+0.25%)
     
  • Bitcoin USD

    63,808.43
    +269.77 (+0.42%)
     
  • CMC Crypto 200

    1,320.15
    -44.97 (-3.29%)
     
  • FTSE 100

    8,313.67
    +100.18 (+1.22%)
     
  • Gold

    2,322.70
    -8.50 (-0.36%)
     
  • Crude Oil

    78.13
    -0.35 (-0.45%)
     
  • 10-Yr Bond

    4.4310
    -0.0580 (-1.29%)
     
  • Nikkei

    38,835.10
    +599.03 (+1.57%)
     
  • Hang Seng

    18,479.37
    -98.93 (-0.53%)
     
  • FTSE Bursa Malaysia

    1,605.68
    +8.29 (+0.52%)
     
  • Jakarta Composite Index

    7,123.61
    -12.28 (-0.17%)
     
  • PSE Index

    6,618.58
    -33.91 (-0.51%)
     

As Prospects Dim, Juul Slashes $7 Billion From Valuation

As Prospects Dim, Juul Slashes $7 Billion From Valuation

With the prospects for global growth rapidly diminishing, electronic cigarette maker Juul Labs slashed its internal valuation by $7 billion, eliminating some 35% from the total and bringing it closer to the value assigned to it by its biggest investor, Altria (NYSE: MO). It's a major reversal for Juul Labs, and its tobacco giant partner too, as not too long ago the smoking-alternative leader saw significant expansion opportunities worldwide. Altria, after taking a $12.8 billion stake in Juul in 2018, has since written off three-quarters of the value of the investment.